Somnath Chakraborty, MD » Post Brolucizumab IOI

  • Fundus Photo Montage showing Occlusive Vascultis from Brolucizumab

    Jan 21 2022 by Somnath Chakraborty, MD

    Right eye of a 62-year-old lady with Inferotemporal Branch Retinal Vein Occlusion, treated with single dose of "off-label" brolucizumab. She developed Occlusive Vasculitis 9 weeks post injection. This is her Fundus Photo Montage at that time, showing evidence of Occlusive Vasculitis with moderate grade vitritis. BCVA OD 20/400.

    Photographer: Pulak Roy

    Condition/keywords: branch retinal vein occlusion (BRVO), Brolucizumab, occlusive vasculitis, vitritis

  • Fundus Photo Montage showing Occlusive Vasculitis from Brolucizumab: 1-week post treatment with Steroids

    Jan 21 2022 by Somnath Chakraborty, MD

    Right eye of a 62-year old lady with inferotemporal Branch Retinal Vein Occlusion, treated with single dose of "off-label" brolucizumab. She developed Occlusive Vasculitis 9 weeks post injection. We treated her with topical and systemic steroids. This is her Fundus Photo Montage after 1 week of therapy. BCVA OD 20/200.

    Photographer: Pulak Roy

    Condition/keywords: branch retinal vein occlusion (BRVO), Brolucizumab, occlusive vasculitis

  • Fundus Photo Montage showing Occlusive Vasculitis from Brolucizumab: 3 weeks Post treatment with Steroids

    Jan 21 2022 by Somnath Chakraborty, MD

    Right eye of a 62-year-old lady with inferotemporal Branch Retinal Vein Occlusion, treated with single dose of "off-label" brolucizumab. She developed Occlusive Vasculitis 9 weeks post injection. We treated her with topical and systemic steroids. This is her Fundus Photo Montage, 3 weeks after therapy. BCVA OD 20/80.

    Photographer: Pulak Roy

    Condition/keywords: branch retinal vein occlusion (BRVO), Brolucizumab, occlusive vasculitis